Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 13.72 Million USD | 1900.37% |
| 2022 | 686.09 Thousand USD | -70.23% |
| 2021 | 2.3 Million USD | 5.82% |
| 2020 | 2.17 Million USD | 52.1% |
| 2019 | 1.43 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | 654.39 Thousand USD | -4.62% |
| 2023 FY | 13.72 Million USD | 1900.37% |
| 2023 Q4 | 13.72 Million USD | 268.67% |
| 2023 Q3 | 3.72 Million USD | 430.45% |
| 2023 Q2 | 701.79 Thousand USD | 7.24% |
| 2022 Q3 | 728.04 Thousand USD | -66.84% |
| 2022 Q4 | 686.09 Thousand USD | -5.76% |
| 2022 FY | 686.09 Thousand USD | -70.23% |
| 2022 Q1 | 2.46 Million USD | 7.09% |
| 2022 Q2 | 2.19 Million USD | -11.05% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 2.3 Million USD | 5.82% |
| 2021 Q4 | 2.3 Million USD | -9.74% |
| 2021 Q3 | 2.55 Million USD | 0.0% |
| 2020 FY | 2.17 Million USD | 52.1% |
| 2020 Q4 | 2.07 Million USD | 0.0% |
| 2019 FY | 1.43 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 540.94 Million USD | 97.463% |
| Theratechnologies Inc. | 58.96 Million USD | 76.726% |
| Safety Shot Inc | 1.54 Million USD | -786.038% |
| Cosmos Health Inc. | 12.42 Million USD | -10.468% |
| Cronos Group Inc. | 2.53 Million USD | -440.348% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 98.082% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | 62.215% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 88.501% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -150.335% |
| ProPhase Labs, Inc. | 21.38 Million USD | 35.807% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -2157.32% |
| Dynavax Technologies Corporation | 256.91 Million USD | 94.658% |
| Radius Health, Inc. | 365.31 Million USD | 96.243% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -418.404% |
| Alvotech | 1.07 Billion USD | 98.724% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -1986.727% |
| Alpha Teknova, Inc. | 30.45 Million USD | 54.94% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | 18.972% |
| SCYNEXIS, Inc. | 15.08 Million USD | 8.989% |
| Harrow Health, Inc. | 190.5 Million USD | 92.796% |
| Biofrontera Inc. | 5.39 Million USD | -154.205% |
| DURECT Corporation | 20.74 Million USD | 33.845% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | 66.95% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 95.648% |
| OptiNose, Inc. | 131.74 Million USD | 89.583% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -1070.029% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | 86.112% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | 25.526% |
| SIGA Technologies, Inc. | 1.46 Million USD | -837.46% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 89.472% |
| Shineco, Inc. | 29.65 Million USD | 53.722% |
| Phibro Animal Health Corporation | 525.45 Million USD | 97.388% |
| Procaps Group S.A. | 285.93 Million USD | 95.2% |
| TherapeuticsMD, Inc. | 8 Million USD | -71.449% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -22847.991% |
| Viatris Inc. | 18.12 Billion USD | 99.924% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -1986.727% |
| Rockwell Medical, Inc. | 13.43 Million USD | -2.124% |
| Incannex Healthcare Limited | 373 Thousand USD | -3579.492% |
| Aytu BioPharma, Inc. | 15.12 Million USD | 9.283% |
| Tilray Brands, Inc. | 387.31 Million USD | 96.457% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 97.965% |
| PetIQ, Inc. | 468.3 Million USD | 97.069% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 96.796% |
| Journey Medical Corporation | 17.73 Million USD | 22.592% |
| Alimera Sciences, Inc. | 67.39 Million USD | 79.637% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -65.823% |
| Assertio Holdings, Inc. | 40.91 Million USD | 66.454% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -1161.798% |
| Embecta Corp. | 1.63 Billion USD | 99.162% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -1228.459% |
| Procaps Group, S.A. | 285.93 Million USD | 95.2% |
| PainReform Ltd. | 86 Thousand USD | -15858.727% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | 61.213% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 97.658% |
| Alvotech | 1.07 Billion USD | 98.724% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 97.775% |
| Kamada Ltd. | 8.74 Million USD | -56.87% |
| Indivior PLC | 281.6 Million USD | 95.126% |
| Currenc Group, Inc. | 31.94 Million USD | 57.035% |
| Evoke Pharma, Inc. | 5 Million USD | -174.49% |
| Flora Growth Corp. | 3.67 Million USD | -273.761% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -1228.459% |
| Evolus, Inc. | 126.54 Million USD | 89.155% |
| HUTCHMED (China) Limited | 86.13 Million USD | 84.066% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 97.799% |
| Akanda Corp. | 3.99 Million USD | -243.216% |